Cormorant Asset Management, LP - Oct 15, 2024 Form 3 Insider Report for BRIGHT MINDS BIOSCIENCES INC. (DRUG)

Role
10%+ Owner
Signature
CORMORANT ASSET MANAGEMENT, LP By: /s/ Bihua Chen, Managing Member
Stock symbol
DRUG
Transactions as of
Oct 15, 2024
Transactions value $
$0
Form type
3
Date filed
10/17/2024, 05:07 PM
Previous filing
Oct 15, 2024
Next filing
Nov 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DRUG Common Shares 452K Oct 15, 2024 See Footnotes F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
F2 Represents 452,409 shares beneficially owned by the Master Fund.